Key result
N-deacetyllappaconitine relaxes aortic rings, reducing phenylephrine-induced contraction by ~85%.
Why the study?
Disruption of Ca²⁺ homeostasis in vascular smooth muscle cells is a decisive factor in cardiovascular disease pathogenesis, motivating a comprehensive assessment of the mechanisms underlying the vasorelaxant effects of the alkaloid N-deacetyllappaconitine on rat aortic rings.
Does the alkaloid N-deacetyllappaconitine induce vasorelaxation by reducing isometric contraction force in isolated rat aortic rings pre-contracted with KCl or phenylephrine?
Does the alkaloid N-deacetyllappaconitine induce vasorelaxation by reducing isometric contraction force in isolated rat aortic rings pre-contracted with KCl or phenylephrine?
N-deacetyllappaconitine produces potent, primarily endothelium-independent vasorelaxation in rat aortic smooth muscle by inhibiting L-type Ca2+ channels, IP3 receptors, and the reverse-mode Na+/Ca2+ exchanger.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications; leaves open further preclinical testing of N-deacetyllappaconitine in vascular models.
In the pathogenesis of cardiovascular diseases, disruption of Ca²⁺ homeostasis in vascular smooth muscle cells and the dysregulation of vasoregulatory mechanisms are considered decisive factors. In particular, dysfunction of the Ca²⁺ transport systems in the plasma membrane and the sarcoplasmic reticulum, and the resulting imbalance of endothelium-dependent vasoactive and regulatory factors, play a crucial role. The aim of this study is to comprehensively assess the mechanisms of the vasorelaxant effects of the alkaloid N-deacetyllappaconitine on rat aortic rings. The isometric contraction force of the aortic rings was recorded using a Grass-Telefactor FT.03 myograph and analysed with the PowerLab data-acquisition software (ADInstruments). The results showed that the N-deacetyllappaconitine alkaloid exerts a dose-dependent vasorelaxant effect on KCl- and PE-induced aortic contractions. N-deacetyllappaconitine alkaloids reduce intracellular Ca²⁺ levels by inhibiting L-type Ca²⁺ channels in the plasma membrane and by attenuating IP₃ receptor activity. Furthermore, by partially activating KATP channels, it causes membrane hyperpolarisation and, by inhibiting the reverse mode of the Na⁺/Ca²⁺ exchange system, slows the influx of Ca²⁺ ions into the cell. Thus, the relaxant effect of the alkaloid N-deacetyllappaconitine on aortic rings is realised through a number of complex mechanisms. HIGHLIGHTS It was established that the vasorelaxant effect of the alkaloid N-deacetyllappaconitine in rat aortic rings is mediated through several complex mechanisms. The vasorelaxant effect of the alkaloid N-deacetyllappaconitine is primarily mediated via non-endothelial mechanisms and involves inhibition of Ca²⁺ release through L-type Ca²⁺ channels and IP₃ receptors in the sarcoplasmic reticulum. Also, The alkaloid N-deacetyllappaconitine reduces intracellular Ca²⁺ homeostasis by activating the SERCA pump and, to a lesser extent, the KATP channel, as well as inhibiting the reverse mode of the Na⁺/Ca²⁺ exchanger, thereby causing relaxation in vascular smooth muscle.
No takes yet. Share an insight, caveat, or question.
Sobirov et al. (2026) studied Vascular smooth muscle contraction (preclinical ex vivo rat aortic ring model). N-deacetyllappaconitine (N-DEZ) vs. Untreated control pre-contracted aortic rings (100% contraction force) and verapamil (0.1 - 1 μM) was evaluated on Reduction in phenylephrine (1 μM)-induced isometric aortic contraction force at 150 μM (%) (IC50 38.3 μM (PE-induced); IC50 43.8 μM (KCl-induced), p=<0.01). N-deacetyllappaconitine dose-dependently relaxed rat aortic rings, reducing phenylephrine-induced contraction by 85.2% and KCl-induced contraction by 79.8%.
Synapse has enriched 10 related papers. Consider them for comparative context: